Insights into Muscle Contraction Derived from the Effects of Small-Molecular Actomyosin-Modulating Compounds

Bottom-up mechanokinetic models predict ensemble function of actin and myosin based on parameter values derived from studies using isolated proteins. To be generally useful, e.g., to analyze disease effects, such models must also be able to predict ensemble function when actomyosin interaction kinetics are modified differently from normal. Here, we test this capability for a model recently shown to predict several physiological phenomena along with the effects of the small molecular compound blebbistatin. We demonstrate that this model also qualitatively predicts effects of other well-characterized drugs as well as varied concentrations of MgATP. However, the effects of one compound, amrinone, are not well accounted for quantitatively. We therefore systematically varied key model parameters to address this issue, leading to the increased amplitude of the second sub-stroke of the power stroke from 1 nm to 2.2 nm, an unchanged first sub-stroke (5.3–5.5 nm), and an effective cross-bridge attachment rate that more than doubled. In addition to better accounting for the effects of amrinone, the modified model also accounts well for normal physiological ensemble function. Moreover, a Monte Carlo simulation-based version of the model was used to evaluate force–velocity data from small myosin ensembles. We discuss our findings in relation to key aspects of actin–myosin operation mechanisms causing a non-hyperbolic shape of the force–velocity relationship at high loads. We also discuss remaining limitations of the model, including uncertainty of whether the cross-bridge elasticity is linear or not, the capability to account for contractile properties of very small actomyosin ensembles (<20 myosin heads), and the mechanism for requirements of a higher cross-bridge attachment rate during shortening compared to during isometric contraction.

[1]  M. Ušaj,et al.  Multistep orthophosphate release tunes actomyosin energy transduction , 2022, Nature Communications.

[2]  T. Hisada,et al.  A reverse stroke characterizes the force generation of cardiac myofilaments, leading to an understanding of heart function , 2021, Proceedings of the National Academy of Sciences.

[3]  T. Ando,et al.  Millisecond Conformational Dynamics of Skeletal Myosin II Power Stroke Studied by High-Speed Atomic Force Microscopy. , 2020, ACS nano.

[4]  A. Månsson Hypothesis: Single Actomyosin Properties Account for Ensemble Behavior in Active Muscle Shortening and Isometric Contraction , 2020, International journal of molecular sciences.

[5]  J. Spudich,et al.  Single Residue Variation in Skeletal Muscle Myosin Enables Direct and Selective Drug Targeting for Spasticity and Muscle Stiffness , 2020, Cell.

[6]  V. Lombardi,et al.  A Myosin II-Based Nanomachine Devised for the Study of Ca2+-Dependent Mechanisms of Muscle Regulation , 2020, bioRxiv.

[7]  G. Piazzesi,et al.  Orthophosphate increases the efficiency of slow muscle-myosin isoform in the presence of omecamtiv mecarbil , 2020, Nature Communications.

[8]  G. Piazzesi,et al.  Straightening Out the Elasticity of Myosin Cross-Bridges. , 2020, Biophysical journal.

[9]  A. Månsson The effects of inorganic phosphate on muscle force development and energetics: challenges in modelling related to experimental uncertainties , 2019, Journal of Muscle Research and Cell Motility.

[10]  A. Månsson Comparing models with one versus multiple myosin-binding sites per actin target zone: The power of simplicity , 2019, The Journal of general physiology.

[11]  A. Månsson,et al.  Nonlinear Actomyosin Elasticity in Muscle? , 2018, Biophysical journal.

[12]  D. Rassier,et al.  The load dependence and the force-velocity relation in intact myosin filaments from skeletal and smooth muscles. , 2019, American journal of physiology. Cell physiology.

[13]  Michael S. Woody,et al.  Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the myosin working stroke , 2018, Nature Communications.

[14]  Anna Á. Rauscher,et al.  Targeting Myosin by Blebbistatin Derivatives: Optimization and Pharmacological Potential. , 2018, Trends in biochemical sciences.

[15]  Dan Cojoc,et al.  A myosin II nanomachine mimicking the striated muscle , 2018, Nature Communications.

[16]  A. Månsson,et al.  Blebbistatin Effects Expose Hidden Secrets in the Force-Generating Cycle of Actin and Myosin , 2018, Biophysical journal.

[17]  A. Månsson,et al.  Do Actomyosin Single-Molecule Mechanics Data Predict Mechanics of Contracting Muscle? , 2018, International journal of molecular sciences.

[18]  Yin-Biao Sun,et al.  Omecamtiv mercabil and blebbistatin modulate cardiac contractility by perturbing the regulatory state of the myosin filament , 2017, The Journal of physiology.

[19]  V. J. Planelles-Herrero,et al.  Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil , 2017, Nature Communications.

[20]  J. Spudich,et al.  Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light , 2017, Biophysical Reviews.

[21]  T. Hisada,et al.  Coordinated force generation of skeletal myosins in myofilaments through motor coupling , 2017, Nature Communications.

[22]  Joseph M. Muretta,et al.  Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke , 2017, Proceedings of the National Academy of Sciences.

[23]  K. Campbell,et al.  Omecamtiv Mecarbil Enhances the Duty Ratio of Human β-Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle* , 2017, The Journal of Biological Chemistry.

[24]  O. Schmitt The heat of shortening and the dynamic constants of muscle , 2017 .

[25]  A. Månsson Actomyosin based contraction: one mechanokinetic model from single molecules to muscle? , 2016, Journal of Muscle Research and Cell Motility.

[26]  C. Reggiani,et al.  Mechanosensing in Myosin Filament Solves a 60 Years Old Conflict in Skeletal Muscle Modeling between High Power Output and Slow Rise in Tension , 2016, Front. Physiol..

[27]  G. Piazzesi,et al.  Force generation by skeletal muscle is controlled by mechanosensing in myosin filaments , 2015, Nature.

[28]  Michael S. Carter,et al.  Velocities of unloaded muscle filaments are not limited by drag forces imposed by myosin cross-bridges , 2015, Proceedings of the National Academy of Sciences.

[29]  Ann M Stock,et al.  Structural basis for drug-induced allosteric changes to human β-cardiac myosin motor activity , 2015, Nature Communications.

[30]  J. Spudich,et al.  Ensemble Force Changes that Result from Human Cardiac Myosin Mutations and a Small-Molecule Effector , 2015, Cell reports.

[31]  Yingying Liu,et al.  Omecamtiv Mecarbil modulates the kinetic and motile properties of porcine β-cardiac myosin. , 2015, Biochemistry.

[32]  Serena Sirigu,et al.  How actin initiates the motor activity of Myosin. , 2015, Developmental cell.

[33]  T. Burghardt,et al.  Analytical Comparison of Natural and Pharmaceutical Ventricular Myosin Activators , 2014, Biochemistry.

[34]  J. Spudich,et al.  Hypertrophic and Dilated Cardiomyopathy: Four Decades of Basic Research on Muscle Lead to Potential Therapeutic Approaches to These Devastating Genetic Diseases , 2014, Biophysical journal.

[35]  E. Debold,et al.  Direct observation of phosphate inhibiting the force-generating capacity of a miniensemble of Myosin molecules. , 2013, Biophysical journal.

[36]  Malin Persson,et al.  Nonlinear cross-bridge elasticity and post-power-stroke events in fast skeletal muscle actomyosin. , 2013, Biophysical journal.

[37]  Marco Linari,et al.  The working stroke of the myosin II motor in muscle is not tightly coupled to release of orthophosphate from its active site , 2013, The Journal of physiology.

[38]  J. Sellers,et al.  Temperature dependent measurements reveal similarities between muscle and non-muscle myosin motility , 2012, Journal of Muscle Research and Cell Motility.

[39]  Sam Walcott,et al.  Mechanical coupling between myosin molecules causes differences between ensemble and single-molecule measurements. , 2012, Biophysical journal.

[40]  A. Cornachione,et al.  A non-cross-bridge, static tension is present in permeabilized skeletal muscle fibers after active force inhibition or actin extraction. , 2012, American journal of physiology. Cell physiology.

[41]  J. Cleland,et al.  The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial , 2011, The Lancet.

[42]  D. Cox,et al.  Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure , 2011, Science.

[43]  F. Minozzo,et al.  Effects of blebbistatin and Ca2+ concentration on force produced during stretch of skeletal muscle fibers. , 2010, American journal of physiology. Cell physiology.

[44]  M. Kaya,et al.  Nonlinear Elasticity and an 8-nm Working Stroke of Single Myosin Molecules in Myofilaments , 2010, Science.

[45]  Alf Månsson,et al.  Actomyosin-ADP states, interhead cooperativity, and the force-velocity relation of skeletal muscle. , 2010, Biophysical journal.

[46]  A. Málnási-Csizmadia,et al.  Myosin complexed with ADP and blebbistatin reversibly adopts a conformation resembling the start point of the working stroke , 2010, Proceedings of the National Academy of Sciences.

[47]  R. Candau,et al.  Drug Effect Unveils Inter-head Cooperativity and Strain-dependent ADP Release in Fast Skeletal Actomyosin* , 2009, The Journal of Biological Chemistry.

[48]  R. Cooke,et al.  Myosin regulatory light chain phosphorylation inhibits shortening velocities of skeletal muscle fibers in the presence of the myosin inhibitor blebbistatin , 2009, Journal of Muscle Research and Cell Motility.

[49]  Martin Karplus,et al.  The elastic properties of the structurally characterized myosin II S2 subdomain: a molecular dynamics and normal mode analysis. , 2008, Biophysical journal.

[50]  A. Stewart,et al.  Skeletal Muscle Performance Determined by Modulation of Number of Myosin Motors Rather Than Motor Force or Stroke Size , 2007, Cell.

[51]  M. Geeves,et al.  What limits the velocity of fast-skeletal muscle contraction in mammals? , 2006, Journal of molecular biology.

[52]  V Lombardi,et al.  Two independent mechanical events in the interaction cycle of skeletal muscle myosin with actin. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Patlak,et al.  Slip sliding away: load-dependence of velocity generated by skeletal muscle myosin molecules in the laser trap. , 2005, Biophysical journal.

[54]  K. Edman,et al.  Contractile properties of mouse single muscle fibers, a comparison with amphibian muscle fibers , 2005, Journal of Experimental Biology.

[55]  I. Rayment,et al.  The structural basis of blebbistatin inhibition and specificity for myosin II , 2005, Nature Structural &Molecular Biology.

[56]  R. Cooke,et al.  Simulation of stochastic processes in motile crossbridge systems , 1991, Journal of Muscle Research & Cell Motility.

[57]  A. Straight,et al.  Kinetic mechanism of blebbistatin inhibition of nonmuscle myosin IIb. , 2004, Biochemistry.

[58]  J. Sellers,et al.  Mechanism of Blebbistatin Inhibition of Myosin II* , 2004, Journal of Biological Chemistry.

[59]  A. Huxley,et al.  Rapid regeneration of power stroke in contracting muscle by attachment of second myosin head , 1997, Journal of Muscle Research & Cell Motility.

[60]  S. Tideswell,et al.  Filament compliance and tension transients in muscle , 1996, Journal of Muscle Research & Cell Motility.

[61]  G. Maréchal,et al.  The force-velocity relation of the rabbit inferior oblique muscle; influence of temperature , 1994, Pflügers Archiv.

[62]  C. Reggiani,et al.  Effects of amrinone on shortening velocity and force development in skinned skeletal muscle fibres , 1993, Journal of Muscle Research & Cell Motility.

[63]  A. Arner,et al.  Cardiotonic bipyridine amrinone slows myosin-induced actin filament sliding at saturating [MgATP] , 2004, Journal of Muscle Research & Cell Motility.

[64]  Timothy J Mitchison,et al.  Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II Inhibitor , 2003, Science.

[65]  C. Reggiani,et al.  Orthologous myosin isoforms and scaling of shortening velocity with body size in mouse, rat, rabbit and human muscles , 2003, The Journal of physiology.

[66]  T. Duke,et al.  Molecular model of muscle contraction. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Frank Jülicher,et al.  Acting on actin: the electric motility assay , 1999, European Biophysics Journal.

[68]  K. Edman,et al.  The Biphasic Force–Velocity Relationship in Frog Muscle Fibres and its Evaluation in Terms of Cross‐Bridge Function , 1997, The Journal of physiology.

[69]  H. Westerblad,et al.  The effect of intracellular pH on contractile function of intact, single fibres of mouse muscle declines with increasing temperature. , 1997, The Journal of physiology.

[70]  U. A. van der Heide,et al.  Strain dependence of the elastic properties of force-producing cross-bridges in rigor skeletal muscle. , 1997, Biophysical journal.

[71]  G. Piazzesi,et al.  A cross-bridge model that is able to explain mechanical and energetic properties of shortening muscle. , 1995, Biophysical journal.

[72]  B. Brenner,et al.  On the regeneration of the actin-myosin power stroke in contracting muscle. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[73]  G. Piazzesi,et al.  Rapid regeneration of the actin-myosin power stroke in contracting muscle , 1992, Nature.

[74]  G. Piazzesi,et al.  Tension transients during steady lengthening of tetanized muscle fibres of the frog. , 1992, The Journal of physiology.

[75]  J. Spudich,et al.  Myosin step size. Estimation from slow sliding movement of actin over low densities of heavy meromyosin. , 1990, Journal of molecular biology.

[76]  A. Månsson,et al.  Effects of amrinone on the electromechanical coupling in frog skeletal muscle fibres. , 1990, Acta physiologica Scandinavica.

[77]  A. Månsson Changes in force and stiffness during stretch of skeletal muscle fibers, effects of hypertonicity. , 1989, Biophysical journal.

[78]  K. Edman,et al.  Effects of amrinone on twitch, tetanus and shortening kinetics in mammalian skeletal muscle. , 1989, Acta physiologica Scandinavica.

[79]  K. Edman,et al.  Effects of amrinone on the contractile behaviour of frog striated muscle fibres. , 1985, Acta physiologica Scandinavica.

[80]  K W Ranatunga,et al.  The force‐velocity relation of rat fast‐ and slow‐twitch muscles examined at different temperatures. , 1984, The Journal of physiology.

[81]  R. Simmons,et al.  The dependence of force and shortening velocity on substrate concentration in skinned muscle fibres from Rana temporaria. , 1984, The Journal of physiology.

[82]  T. L. Hill,et al.  Cross-bridge model of muscle contraction. Quantitative analysis. , 1980, Biophysical journal.

[83]  W Bialek,et al.  Contraction of glycerinated muscle fibers as a function of the ATP concentration. , 1979, Biophysical journal.

[84]  G. Y. Lesher,et al.  Cardiotonic Activity of Amrinone–Win 40680 [5‐Amino‐3,4f‐bipyridin‐6(lH)‐one] , 1979, Circulation research.

[85]  T. L. Hill,et al.  A cross-bridge model of muscle contraction. , 1978, Progress in biophysics and molecular biology.

[86]  D. Gillespie A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions , 1976 .

[87]  T. L. Hill Theoretical formalism for the sliding filament model of contraction of striated muscle. Part II. , 1975, Progress in biophysics and molecular biology.

[88]  T. L. Hill,et al.  Theoretical formalism for the sliding filament model of contraction of striated muscle. Part I. , 1974, Progress in biophysics and molecular biology.

[89]  A. Huxley,et al.  Proposed Mechanism of Force Generation in Striated Muscle , 1971, Nature.

[90]  A. Huxley Muscle structure and theories of contraction. , 1957, Progress in biophysics and biophysical chemistry.